Experimental and Molecular Medicine (Jun 2019)

Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation

  • Kyeong-Min Kim,
  • Do-Young Kim,
  • Dong-Seok Lee,
  • Jung-Woo Kim,
  • Jeong-Tae Koh,
  • Eun-Jung Kim,
  • Won-Gu Jang

DOI
https://doi.org/10.1038/s12276-019-0263-x
Journal volume & issue
Vol. 51, no. 6
pp. 1 – 11

Abstract

Read online

Bone health: Enzyme protects against damage during stress An antioxidant enzyme actively works to reduce bone synthesis under oxidative stress conditions in order to protect bone cells from damage and cell death. Bone is generated by cells called osteoblasts, which differentiate from stem cells. In osteoporosis and diabetes, excessive reactive oxygen species (ROS) within cells can disrupt osteoblast differentiation. South Korean researchers led by Eun-jung Kim at Kyungpook National University, Daegu, and Won-Gu Jang at Daegu University, Gyeongbuk, have shown that an antioxidant enzyme, peroxiredoxin II (PrxII), helps regulate bone formation under oxidative stress. The team generated PrxII-deficient mice and compared them with healthy normal mice. Under oxidative stress conditions, the mice had higher bone mass and higher expression of genes related to bone formation than the normal mice. PrxII limits osteoblast differentiation during elevated ROS by influencing associated protein activity and signalling pathways.